Latest Report Available at Orbis research Spinal Cord
Stimulation Market provides pin-point analysis for changing competitive
dynamics and a forward looking perspective on different factors driving or
restraining industry growth.
Request sample
copy of this report @ http://www.orbisresearch.com/contacts/request-sample/415043 .
Spinal cord stimulation (SCS) is a therapy for people who are not
relieved from back or neck pain by surgeries and other treatments. It helps to
treat pain by hiding pain signals before reaching brain. A device is implanted
in body to deliver the signals to spinal cord. Battery attached to pulse
generator are of two types, non-rechargeable and rechargeable batteries for the
power demand of device.
Failed back surgery is the most common reason for spinal cord
stimulation surgery. SCS is a two step process to determine whether spinal cord
stimulation will work for the patients or not. Trial spinal cord stimulation is
a test drive to determine if therapy will provide pain relief to the patient or
not. After the implantation in trial, patient considers the permanent
implantation of device based on pain relief improvement.
The U.S. is the main contributor to the SCS market with increasing
chronic back pain prevalence and rising addressable population for SCS. The
U.S. has great potential in the years ahead with favorable reimbursement
policies and improved health service quality. The growth of SCS outside the
U.S. is driven by increasing awareness and need for new therapies and devices.
The market is relatively small due to lack of reimbursements, that limits the
growth of the market.
The global SCS market is expected to grow in future due to growing
ageing population, increase in health care expenditure and rising obese
population. Key trends of this market include favorable reimbursement landscape
in the U.S., launch of new products, awareness regarding early treatments,
increase in trial SCS treatments, increasing demand for minimally invasive surgeries,
increase SCS for predominant back pain and rising mergers & acquisitions
activities. However, high cost of treatment, tough regulatory problems and
dependency on traditional therapies are some of the factors posing challenge
for the market growth.
The report “Global Spinal Cord Stimulation Market: Industry Analysis
& Outlook (2017-2021)” by Koncept Analytics provides an extensive research
and detailed analysis of the present market along with future outlook. The
report discusses the major growth drivers and challenges of the market,
covering the U.S. and Outside the U.S. region. The report profiles the key
players of the market including Nevro Corporation, Medtronic Plc., Abbott
Laboratories (St. Jude) and Boston Scientific.
Browse
Complete Report @ http://www.orbisresearch.com/reports/index/global-spinal-cord-stimulation-market-industry-analysis-and-outlook-2017-2021
.
Some points from TOC:
1. Market Overview
1.1 Introduction
1.2 Spinal Cord Stimulation Devices
1.3 Conditions for SCS Treatment
1.4 Spinal Cord Stimulation Therapies
1.5 Surgical Procedures
1.1 Introduction
1.2 Spinal Cord Stimulation Devices
1.3 Conditions for SCS Treatment
1.4 Spinal Cord Stimulation Therapies
1.5 Surgical Procedures
2. Global Spinal Cord Stimulation (SCS) Market
2.1 Global SCS Market Forecast by Value
2.2 Global SCS Market by Region
2.3 Global SCS Addressable Population Forecast
2.4 Global SCS System Implant Volume Forecast
2.1 Global SCS Market Forecast by Value
2.2 Global SCS Market by Region
2.3 Global SCS Addressable Population Forecast
2.4 Global SCS System Implant Volume Forecast
3. Regional Market
3.1 The U.S.
3.1.1 The U.S. Chronic Back Pain Prevalence Forecast
3.1.2 The U.S. SCS Market Forecast by Value
3.1.3 The U.S. Addressable SCS Population Forecast
3.1.4 The U.S. SCS System Implant Volume Forecast
3.2 Outside the U.S.
3.2.1 Outside the U.S. SCS Market Forecast by Value
3.2.2 Outside the U.S. SCS Addressable Population Forecast
3.2.3 Outside the U.S. SCS System Implant Volume Forecast
3.2.4 Outside the U.S. Rechargeable SCS Market Forecast by Value
3.1 The U.S.
3.1.1 The U.S. Chronic Back Pain Prevalence Forecast
3.1.2 The U.S. SCS Market Forecast by Value
3.1.3 The U.S. Addressable SCS Population Forecast
3.1.4 The U.S. SCS System Implant Volume Forecast
3.2 Outside the U.S.
3.2.1 Outside the U.S. SCS Market Forecast by Value
3.2.2 Outside the U.S. SCS Addressable Population Forecast
3.2.3 Outside the U.S. SCS System Implant Volume Forecast
3.2.4 Outside the U.S. Rechargeable SCS Market Forecast by Value
Purchase a copy of Spinal Cord Stimulation Market visit @ http://www.orbisresearch.com/contact/purchase/415043 For more information contact sales@orbisresearch.com
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Rising Ageing Population
4.1.2 Increasing Healthcare Spending
4.1.3 Rising GDP Per Capita
4.1.4 Increase in Obese Population
4.2 Key Trends & Developments
4.2.1 Increase in Trial Units for SCS in the U.S.
4.2.2 Mergers and Acquisitions
4.2.3 Increasing SCS Implants for Predominant Back Pain in the U.S.
4.2.4 Accelerating Use of Percutaneous Lead Technology in SCS Treatments
4.2.5 Increasing Demand for Minimally Invasive Devices
4.2.6 Rising Awareness of Early Treatment for Chronic Pain
4.2.7 New Product Launches
4.2.8 Burden of Chronic Pain in the U.S.
4.2.9 Favorable Reimbursement Policies in the U.S.
4.3 Challenges
4.3.1 Dependence on Traditional Therapies
4.3.2 High Cost Related to SCS Treatment
4.3.3 Tough Regulatory Problems
4.1 Growth Drivers
4.1.1 Rising Ageing Population
4.1.2 Increasing Healthcare Spending
4.1.3 Rising GDP Per Capita
4.1.4 Increase in Obese Population
4.2 Key Trends & Developments
4.2.1 Increase in Trial Units for SCS in the U.S.
4.2.2 Mergers and Acquisitions
4.2.3 Increasing SCS Implants for Predominant Back Pain in the U.S.
4.2.4 Accelerating Use of Percutaneous Lead Technology in SCS Treatments
4.2.5 Increasing Demand for Minimally Invasive Devices
4.2.6 Rising Awareness of Early Treatment for Chronic Pain
4.2.7 New Product Launches
4.2.8 Burden of Chronic Pain in the U.S.
4.2.9 Favorable Reimbursement Policies in the U.S.
4.3 Challenges
4.3.1 Dependence on Traditional Therapies
4.3.2 High Cost Related to SCS Treatment
4.3.3 Tough Regulatory Problems
About Us:
Orbis Research (orbisresearch.com) is a single point aid
for all your market research requirements. We have vast database of reports
from the leading publishers and authors across the globe. We specialize in
delivering customized reports as per the requirements of our clients. We have
complete information about our publishers and hence are sure about the accuracy
of the industries and verticals of their specialization. This helps our clients
to map their needs and we produce the perfect required market research study
for our clients.
Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214)
884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Follow us on Twitter: https://twitter.com/orbisresearch
Like us on Facebook: https://www.facebook.com/pages/Orbis-Research/820969017982115
No comments:
Post a Comment